TROG Cancer Research
Members Login   CQMS Login  

Upcoming Bladder, Kidney and Prostate trials

TROG 16.03 (CORE) - this study aims to show that the addition of SBRT (stereotactic body radiotherapy) to standard of care improves progression free survival for patients with extra-cranial oligiometastatic disease that has spread from their lung, breast and/or prostate cancer

Primary sponsor: Institute of Cancer Research (ICR)
Collaborating groups: TROG

We are thankful to our 14,000 patients who have participated in our research. Please continue the generous support.